TITLE

The association between corticosteroid use and development of fractures among IBD patients in a population-based database

AUTHOR(S)
Bernstein, Charles N.; Blanchard, James F.; Metge, Colleen; Yogendran, Marina
PUB. DATE
August 2003
SOURCE
American Journal of Gastroenterology;Aug2003, Vol. 98 Issue 8, p1797
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
: ObjectiveBecause the rate of fracture among patients with inflammatory bowel disease (IBD) is only slightly higher than that in the general population, it is important to define high-risk groups worthy of diagnostic evaluation or prophylactic interventions. Corticosteroid use has been considered in other diseases to be a risk for fracture, although not all studies in IBD are concordant on this point. We aimed to determine whether patients with IBD drawn from a population-based database who sustain fractures are more likely to have been using corticosteroids than a matched group of IBD patients who did not fracture.: MethodsWe extracted from our population-based University of Manitoba Inflammatory Bowel Disease Epidemiology Database the number of patients with a new diagnosis of fracture between the years 1997–2000. From within our Inflammatory Bowel Disease Epidemiology Database, we extracted a control group of IBD patients who did not develop fractures matched to the case group who did by age, gender, diagnosis, year of diagnosis, and geographic area of residence. We linked our cohorts with Manitoba Health’s Drug Program Information Network to study corticosteroid use within 2 yr before fracture diagnosis. The Drug Program Information Network is a population-based database, established in 1995, which records all prescription drugs.: ResultsFractures were identified in 13 patients with Crohn’s disease and in 28 patients with ulcerative colitis. The control group included 103 Crohn’s disease and 173 ulcerative colitis patients who did not fracture. In Crohn’s disease, for the group who fractured compared with the controls who did not fracture, corticosteroid use before fracture was evident in seven (54%) compared with 21 (22%) who did not fracture (χ2 = 4.45, df = 1, p = 0.035). In ulcerative colitis, for the group who fractured compared with the controls who did not fracture, corticosteroid use before fracture was evident in five (18%) compared with 37 (21%) who did not fracture (χ2 = 0.031, df = 1, p = 0.861). Fracture cases were more likely to be exposed to oral corticosteroids (OR = 1.75; 95% CI = 0.82–3.75), but this result is not significant. Regarding corticosteroid dosing among the 12 patients with IBD who fractured and used corticosteroids, the mean total days supply was 314 days ± 236 days compared with 258 days ± 278 days in those who did not fracture (p = 0.16). The prescribed daily dose among corticosteroid users was comparable for those who fractured versus those who did not fracture (18 mg/day vs 21 mg/day, p = 0.90).: ConclusionsPatients who require corticosteroids in Crohn’s disease should be considered at risk for fracture. Further research is required to delineate after how much corticosteroid use are subjects at risk and/or after what duration of active disease.
ACCESSION #
10428279

 

Related Articles

  • INFLAMMATORY BOWEL DISEASE AND THE RISK OF FRACTURE. van Staa, T.P.; Cooper, C.; Probert, C.S.J.; Leufkens, H.G.M.; Javaid, M.K.; Arden, N. // Gut;Apr2003 Supplement 1, Vol. 52, pA12 

    Patients with inflammatory bowel disease (IBD) have an increased risk of Iow bone mass, the pathogenesis of which is multifactorial. There are limited data on fracture. We therefore conducted a primary care based case-control study to determine the risk and major risk factors of fracture in IBD...

  • Inflammatory Bowel Disease Presenting as Salmonella Colitis: The Importance of Early Histologic Examination in Recognition and Management. Sarigol, Samra; Wyllie, Robert // Clinical Pediatrics;Nov1999, Vol. 38 Issue 11, p669 

    Provides information on a study which focused on the importance of early histologic examination in the recognition and management of inflammatory bowel disease presenting as Salmonella colitis. Patient reports; Discussion; Conclusion.

  • MORE SECRETS OF THE MMR SCARE: Who saw the "histological findings"? Deer, Brian // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;12/10/2011, Vol. 343 Issue 7835, p1205 

    A letter to the editor is presented in response to the article regarding the claim that Wakefield and colleagues have discovered a new inflammatory bowel disease and the relationship between the vaccine and autism in the 2011 issue.

  • RESPONSE: Amar Dhillon replies to pathology riddle. Dhillon, Amar // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;12/10/2011, Vol. 343 Issue 7835, p1205 

    A response by Amar Dhillon to a letter to the editor regarding his histology grading sheets and the misunderstandings in articles regarding the grading sheets in the November 12, 2011 issue is presented.

  • Coloduodenal fistula due to signet-ring cells adenocarcinoma. Macedo, Guilherme; Santos-Antunes, João; Gonçalves, Regina; Lopes, Susana // International Journal of Colorectal Disease;Oct2015, Vol. 30 Issue 10, p1423 

    A letter to the editor is presented, wherein the case of a patient diagnosed with Coloduodenal fistulas with signet-ring cells adenocarcinoma, found together for the first time, is discussed, along with treatment and prognosis in brief.

  • Inflammatory bowel disease in older people. Smith, Graeme D. // Gastrointestinal Nursing;Jul/Aug2013, Vol. 11 Issue 6, p31 

    The physiological process of ageing can lead to a number of health challenges, including a deterioration of gastrointestinal functions and increase in digestive disorders. Therefore, although the occurrence of inflammatory bowel disease (IBD) is quite high in younger people, some individuals can...

  • Inflammatory bowel disease: an overview on assessment. Bettany, Jean; Gardiner, Angela // Nursing & Residential Care;Sep2013, Vol. 15 Issue 9, p607 

    No abstract available.

  • Inflammatory Bowel Disease in the Elderly. Hussain, Syed Wasif; Pardi, Darrell S. // Drugs & Aging;2010, Vol. 27 Issue 8, p617 

    Although inflammatory bowel disease (IBD) is generally considered a disease of young adults, it can occur in elderly individuals. The clinical features and treatment considerations in older patients are similar to those in younger patients, with some notable exceptions, which are reviewed in...

  • Le malattie infiammatorie croniche intestinali in età pediatrica. Pelosi, Paola; Cianchi, Ilaria; Paolacci, Giulia; Gissi, Anna; Paci, Monica; Naldini, Sara; Lionetti, Paolo // Children's Nurses: Italian Journal of Pediatric Nursing Science ;inverno2012/2013, Vol. 4 Issue 4, p122 

    Chronic inflammatory bowel diseases include two important conditions: Crohn disease and Ulcerative Colitis. Although they were considered rare among children in the past, these diseases have seen in the last decades a progressive increase in their incidence also in developing ages, and now they...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics